Skip to main content
. 2021 Jul 16;61(Suppl 1):S243–S251. doi: 10.1111/trf.16455

FIGURE 3.

FIGURE 3

High platelet:plasma, but not high plasma:RBC ratio, improves 24‐h mortality and 30‐day mortality in randomized controlled trials. Meta‐analyses of high and low platelet:plasma ratio on (A) 24‐h and (B) 30‐day mortality and high and low plasma:RBC ratio on (C) 24‐h and (D) 30‐day mortality represented in a forest plot. Weighted mean platelet:plasma ratio in the high ratio group was 1.08 (SD 0.56) and in the low ratio group 0.65 (0.38). Weighted mean plasma:RBC ratio in the high ratio group was 0.70 (0.34) and in the low ratio group 0.53 (0.30). Events = number of deceased, total = total number of patients, high = group with highest platelet:plasma or plasma:RBC ratio, low = group with lowest platelet:plasma or plasma:RBC ratio, M‐H = Mantel–Haenszel